Insider sale
WEREWOLF THERAPEUTICS, INC.
$105.8K
164.13K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 164.13K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $105.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001628280-26-000951
10% Owner
Since Apr 2021
164.13K
Shares to sell
$105.8K
Approx. market value
164.13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
164.13KTotal acquired164.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 164.13K | — |
| Total | 164.13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
164.13K
Market value
$105.8K
1/6/2026
Total
Units
164.13K
Value
$105.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 164.13K | $105.8K | NASDAQ | Planned |
| Total | 164.13K | $105.8K | ||